Add Fazzaco to desktop

Add Fazzaco to desktop

Access Fazzaco from desktop next time

Add now
English

Baird Investment Banking names Derrick Li as managing director of Global Healthcare Team

Source: Fazzaco

a0a28f0bf998b38801cd2ee834b90ac.jpeg

Baird, an employee-owned, international financial services firm, announced that it has hired Derrick Li as Managing Director of Global Healthcare Investment Banking team in order to expand biopharma coverage. In his new role, Li will focus on biopharma, enhancing and expanding the team's existing areas of expertise. 

As seen on his Linkedin profile, prior to joining Baird, Li served as Head of Strategy and Investor Relations for Cellular Biomedicine Group, a NASDAQ-listed, biotechnology company that focuses on cell therapies. Before this role, he was Managing Director of Healthcare Investment Banking at B. Riley Financial. Li also spent four years as a Partner at TPP Healthcare, a boutique advisory firm that specializes in cross-border transactions between companies from the U.S. and China. Li began his career as an equity analyst at The Royce Funds. He holds dual bachelor's degrees in accounting and business administration from Villanova University.

"We are excited that Derrick has decided to continue his career at Baird,"saidRob Andrews, Co-Head of Baird Global Healthcare Investment Banking. "His diverse and complementary set of industry experience and deep healthcare sector knowledge will continue to strengthen our team and overall healthcare offering to our global clients."

Li added: "I'm excited to join this highly-regarded team, especially during a time of growth for the Global Healthcare platform. I look forward to utilizing my expertise and delivering the best possible outcomes for our clients."

Baird's Global Healthcare platform includes more than 40 investment bankers, who have completed 150 healthcare M&A and financing transactions since 2017; 19 Equity Research Analysts covering nearly 150 healthcare stocks; and a dedicated Equity Sales & Trading team that makes a market in approximately 600 healthcare stocks and has traded more than 650 million shares of those stocks in the last twelve months. Baird also recently hosted its annual Healthcare conference. Although it was in a virtual format this year, the conference featured more than 135 presenting companies, 1,700 attendees and 2,300 one-on-one meetings.

Create Company Page